Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Better MedSpa vs JRNYS

Better MedSpa
Graded #402

Lower grade

vs+5.299999999999997
JRNYS
Graded #267

Higher grade

The verdict

JRNYS takes it — 62.5/100 to 57.2/100.

JRNYS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. JRNYS is a telehealth weight-loss membership built around branded GLP-1 medications, and the membership itself buys no medication.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationJRNYS +2
56
58
Clinical oversightJRNYS +7
77
84
Labs & monitoringJRNYS +19
52
71
FulfillmentJRNYS +5
60
65
Contract termsEven
55
55
Better MedSpa · left barJRNYS · right bar

The numbers

MetricBetter MedSpaJRNYS
WeighScore57.2/10062.5/100
GradeCC
Scorecard rank#402#267
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Better MedSpa

Graded #402 · C

Strengths

  • Broad menu: semaglutide, tirzepatide, and liraglutide
  • Both oral and injectable formulations offered
  • Physician-led; medical director Dr. Brett Brechner, DO
  • Both in-person Chicago visits and statewide telehealth
  • Doorstep delivery throughout Illinois

Where it loses points

  • Telehealth limited to Illinois only
  • No pricing published online
  • Compounded vs brand formulation not specified
  • Med-spa positioning blends weight loss with aesthetics
JRNYS

Graded #267 · C

Strengths

  • Branded, FDA-approved GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro and Saxenda — rather than compounded copies
  • The membership band is published before intake and is banded openly by level of coach support
  • Medical visits, daily monitoring and 1-on-1 coaching are included in the membership at every tier
  • Led by CMO Dr. Henry Legere (UC Berkeley, Columbia medicine, Harvard fellowship)
  • Members with commercial insurance may pay around $25 a month for the medication after any deductible

Where it loses points

  • The membership is overhead, not a medication price: it covers visits, monitoring and coaching, and the FAQ says medication pricing is confirmed only after a provider consultation
  • No self-pay drug price is published anywhere, so the cost of a month cannot be worked out before signing up
  • The best case depends on commercial insurance coverage; without it the medication cost is unknown
  • No compounded option is disclosed — the programme is brand-focused, and brand list prices are the dearest route to a GLP-1
  • The states it can prescribe in are not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard